Skip to main content
Yuyu Pharma, Inc. logo

Yuyu Pharma, Inc. — Investor Relations & Filings

Ticker · 000220 ISIN · KR7000220004 KO Manufacturing
Filings indexed 304 across all filing types
Latest filing 2019-03-08 Board/Management Inform…
Country KR South Korea
Listing KO 000220

About Yuyu Pharma, Inc.

https://www.yuyu.co.kr/

Yuyu Pharma, Inc., established in 1941, is a healthcare company focused on the development, manufacturing, and marketing of pharmaceutical products. The company is committed to creating innovative therapeutics to address healthcare challenges and improve quality of life. Its research and development efforts are concentrated on key therapeutic areas, with a notable emphasis on treatments for central nervous system disorders, including Alzheimer's disease. The company operates through several divisions, including Yuyu Healthcare, which provides pharmaceutical-standard Original Design Manufacturer (ODM) and Original Equipment Manufacturer (OEM) services.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the resignation of an outside director for Yuyu Pharmaceutical. This falls under the category of announcements regarding changes in the company's board of directors or senior management.
2019-03-08 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Yuyu Pharmaceutical. It contains the agenda for the upcoming AGM, including financial statement approval, director appointments, and dividend proposals. It also includes detailed financial statements (balance sheets, income statements, cash flow statements) as part of the 'Management Reference' (경영참고사항) required for shareholder review prior to the meeting. This is a standard proxy solicitation document used to inform shareholders of the meeting and provide necessary materials for voting.
2019-02-28 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation' (참고서류) filed by Yuyu Pharma (유유제약) for its 79th Annual General Meeting. It contains detailed information about the company's board, major shareholders, and the agenda for the upcoming meeting, including financial statements (balance sheets, income statements, etc.) as required for shareholder review prior to the vote. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2019-02-28 Korean
주주총회집중일개최사유신고
Regulatory Filings Classification · 95% confidence The document is a formal regulatory filing submitted by Yuyu Pharma regarding the scheduling of its Annual General Meeting (AGM) on a 'concentrated date' (a date where many companies hold their AGMs). It explains the internal reasons for this scheduling choice. Since it is a regulatory notification regarding meeting logistics rather than the meeting materials themselves, the proxy statement, or the voting results, it falls under the general regulatory filing category.
2019-02-28 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Yuyu Pharma regarding the decision to pay cash dividends. It specifies the dividend amount per share, dividend yield, total dividend amount, and the record date. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2019-02-22 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of an upcoming Annual General Meeting (AGM) for Yuyu Pharmaceutical. It details the meeting date, location, agenda items (financial statement approval, dividend declaration, director/auditor appointments, and business purpose changes), and board resolution details. This document serves as the official proxy solicitation and meeting notice sent to shareholders to inform them of the upcoming meeting and request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2019-02-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.